Modes of Action and Species-Specific Effects of Di-(2-ethylhexyl)Phthalate in the Liver

REFERENCES

• (ESCODD) European Standards Committee on Oxidative DNA Damage. Comparative analysis of baseline 8-oxo-7,8-dihydroguanine in mammalian cell DNA, by different methods in different laboratories: an approach to consensus. Carcinogenesis 2002; 23(12)2129–2133, [CSA]
   Google Scholar
• Adinehzadeh M., Reo N. V. Effects of peroxisome proliferators on rat liver phospholipids: sphingomyelin degradation may be involved in hepatotoxic mechanism of perfluorodecanoic acid. Chem. Res. Toxicol. 1998; 11(5)428–440, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Albro P. W. Absorption, metabolism, and excretion of di(2-ethylhexyl) phthalate by rats and mice. Environ Health Perspect. 1986; 65: 293–298, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Albro P. W., Corbett J. T., Schroeder J. L., Jordan S., Matthews H. B. Pharmacokinetics, interactions with macromolecules and species differences in metabolism of DEHP. Environ. Health Perspect. 1982; 45: 19–25, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Aldridge T. C., Tugwood J. D., Green S. Identification and characterization of DNA elements implicated in the regulation of CYP4A1 transcription. Biochem. J. 1995; 306(Pt 2)473–479, [INFOTRIEVE], [CSA]
   Google Scholar
• Anderson S. P., Dunn C. S., Cattley R. C., Corton J. C. Hepatocellular proliferation in response to a peroxisome proliferator does not require TNFalpha signaling. Carcinogenesis 2001; 22(11)1843–1851, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Aoyama T., Peters J. M., Iritani N., Nakajima T., Furihata K., Hashimoto T., Gonzalez F. J. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha). J. Biol. Chem. 1998; 273(10)5678–5684, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Astill B. D. Metabolism of DEHP: effects of prefeeding and dose variation, and comparative studies in rodents and the cynomolgus monkey (CMA studies). Drug. Metab. Rev. 1989; 21(1)35–53, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Badr M. Z., Handler J. A., Whittaker M., Kauffman F. C., Thurman R. G. Interactions between plasticizers and fatty acid metabolism in the perfused rat liver and in vivo. Inhibition of ketogenesis by 2-ethylhexanol. Biochem Pharmacol. 1990; 39(4)715–721, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Barber E. D., Astill B. D., Moran E. J., Schneider B. F., Gray T. J., Lake B. G., Evans J. G. Peroxisome induction studies on seven phthalate esters. Toxicol. Ind. Health. 1987; 3(2)7–24, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Berger J. P., Akiyama T. E., Meinke P. T. PPARs: therapeutic targets for metabolic disease. Trends Pharmacol. Sci. 2005; 26(5)244–251, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Bility M. T., Thompson J. T., McKee R. H., David R. M., Butala J. H., Vanden Heuvel J. P., Peters J. M. Activation of mouse and human peroxisome proliferator-activated receptors (PPARs) by phthalate monoesters. Toxicol. Sci. 2004; 82(1)170–182, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Blount B. C., Silva M. J., Caudill S. P., Needham L. L., Pirkle J. L., Sampson E. J., Lucier G. W., Jackson R. J., Brock J. W. Levels of seven urinary phthalate metabolites in a human reference population. Environ Health Perspect. 2000; 108(10)979–982, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Bojes H. K., Germolec D. R., Simeonova P., Bruccoleri A., Schoonhoven R., Luster M. I., Thurman R. G. Antibodies to tumor necrosis factor alpha prevent increases in cell replication in liver due to the potent peroxisome proliferator, WY- 14,643. Carcinogenesis 1997; 18(4)669–674, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Bojes H. K., Thurman R. G. Peroxisome proliferators activate Kupffer cells in vivo. Cancer Res. 1996; 56(1)1–4, [INFOTRIEVE], [CSA]
   Google Scholar
• Bursch W., Lauer B., Timmermann-Trosiener I., Barthel G., Schuppler J., Schulte-Hermann R. Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters. Carcinogenesis 1984; 5(4)453–458, [INFOTRIEVE], [CSA]
   Google Scholar
• Canitrot Y., Cazaux C., Frechet M., Bouayadi K., Lesca C., Salles B., Hoffmann J. S. Overexpression of DNA polymerase beta in cell results in a mutator phenotype and a decreased sensitivity to anticancer drugs. Proc. Natl. Acad. Sci. USA. 1998; 95(21)12586–12590, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Cattley R. C., Glover S. E. Elevated 8-hydroxydeoxyguanosine in hepatic DNA of rats following exposure to peroxisome proliferators: Relationship to carcinogenesis and nuclear localization. Carcinogenesis 1993; 14: 2495–2499, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Cattley R. C., Marsman D. S., Popp J. A. Age-related susceptibility to the carcinogenic effect of the peroxisome proliferator WY-14,643 in rat liver. Carcinogenesis 1991; 12(3)469–473, [INFOTRIEVE], [CSA]
   Google Scholar
• Cattley R. C., Popp J. A. Differences between the promoting activities of the peroxisome proliferator WY-14,643 and phenobarbital in rat liver. Cancer Res. 1989; 49: 3246–3251, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Cheung C., Akiyama T. E., Ward J. M., Nicol C. J., Feigenbaum L., Vinson C., Gonzalez F. J. Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha. Cancer Res. 2004; 64(11)3849–3854, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Conway J. G., Tomaszewski K. E., Olson M. J., Cattley R. C., Marsman D. S., Popp J. A. Relationship of oxidative damage to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and Wy-14,643. Carcinogenesis 1989; 10(3)513–519, [INFOTRIEVE], [CSA]
   Google Scholar
• Corton J. C., Lapinskas P. J., Gonzalez F. J. Central role of PPARalpha in the mechanism of action of hepatocarcinogenic peroxisome proliferators. Mutat. Res. 2000; 448(2)139–151, [INFOTRIEVE], [CSA]
   Google Scholar
• Currie R. A., Bombail V., Oliver J. D., Moore D. J., Lim F. L., Gwilliam V., Kimber I., Chipman K., Moggs J. G., Orphanides G. Gene ontology mapping as an unbiased method for identifying molecular pathways and processes affected by toxicant exposure: application to acute effects caused by the rodent non-genotoxic carcinogen diethylhexylphthalate. Toxicol. Sci. 2005; 86(2)453–469, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• David R. M., Moore M. R., Cifone M. A., Finney D. C., Guest D. Chronic peroxisome proliferation and hepatomegaly associated with the hepatocellular tumorigenesis of di(2-ethylhexyl)phthalate and the effects of recovery. Toxicol. Sci. 1999; 50(2)195–205, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Deangelo A. B., Garrett C. T., Manolukas L. A., Yario T. Di-n-octyl phthalate (DOP), a relatively ineffective peroxisome inducing straight chain isomer of the environmental contaminant di(2-ethylhexyl)phthalate (DEHP), enhances the development of putative preneoplastic lesions in rat liver. Toxicology 1986; 41(3)279–288, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Decker K. Biologically active products of stimulated liver macrophages (Kupffer cells). Eur. J. Biochem. 1990; 192(2)245–261, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Desvergne B., Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev. 1999; 20(5)649–688, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Diehl A. M. Cytokine regulation of liver injury and repair. Immunol. Rev. 2000; 174: 160–171, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Dirven H. A., van den Broek P. H., Arends A. M., Nordkamp H. H., de Lepper A. J., Henderson P. T., Jongeneelen F. J. Metabolites of the plasticizer di(2-ethylhexyl)phthalate in urine samples of workers in polyvinylchloride processing industries. Int. Arch. Occup. Environ. Health. 1993a; 64(8)549–554, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Dirven H. A., van den Broek P. H., Jongeneelen F. J. Effect of di(2-ethylhexyl)phthalate on enzyme activity levels in liver and serum of rats. Toxicology. 1990; 65(1–2)199–207, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Dirven H. A., van den Broek P. H., Jongeneelen F. J. Determination of four metabolites of the plasticizer di(2-ethylhexyl)phthalate in human urine samples. Int. Arch. Occup. Environ. Health. 1993b; 64(8)555–560, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Dirven H. A., van den Broek P. H., Peeters M. C., Peters J. G., Mennes W. C., Blaauboer B. J., Noordhoek J., Jongeneelen F. J. Effects of the peroxisome proliferator mono(2-ethylhexyl)phthalate in primary hepatocyte cultures derived from rat, guinea pig, rabbit, and monkey. Biochem. Pharmacol. 1993c; 45(12)2425–2434, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Dirven H. A., van den Broek P. H., Peters J. G., Noordhoek J., Jongeneelen F. J. Microsomal lauric acid hydroxylase activities after treatment of rats with three classical cytochrome P450 inducers and peroxisome proliferating compounds. Biochem. Pharmacol. 1992; 43(12)2621–2629, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Duval C., Fruchart J. C., Staels B. PPAR alpha, fibrates, lipid metabolism and inflammation. Arch. Mal. Coeur. Vaiss. 2004; 97(6)665–672, [INFOTRIEVE], [CSA]
   Google Scholar
• Eagon P. K., Teepe A. G., Elm M. S., Tadic S. D., Epley M. J., Beiler B. E., Shinozuka H., Rao K. N. Hepatic hyperplasia and cancer in rats: alterations in copper metabolism. Carcinogenesis 1999; 20(6)1091–1096, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Eason C. T., Powles P., Henry G., Spencer A. J., Pattison A., Bonner F. W. The comparative pharmacokinetics and gastric toxicity of bezafibrate and ciprofibrate in the rat. Xenobiotica 1989; 19(8)913–925, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Elliott B. M., Dodd N. J., Elcombe C. R. Increased hydroxyl radical production in liver peroxisomal fractions from rats treated with peroxisome proliferators. Carcinogenesis 1986; 7(5)795–799, [INFOTRIEVE], [CSA]
   Google Scholar
• Elliott B. M., Elcombe C. R. Lack of DNA damage or lipid peroxidation measured in vivo in the rat liver following treatment with peroxisomal proliferators. Carcinogenesis 1987; 8(9)1213–1218, [INFOTRIEVE], [CSA]
   Google Scholar
• Fan C. Y., Pan J., Usuda N., Yeldandi A. V., Rao M. S., Reddy J. K. Steatohepatitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase. Implications for peroxisome proliferator-activated receptor alpha natural ligand metabolism. J. Biol. Chem. 1998; 273(25)15639–15645, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Fay M., Donohue J. M., De Rosa C. ATSDR evaluation of health effects of chemicals. VI. Di(2-ethylhexyl)phthalate. Agency for Toxic Substances and Disease Registry. Toxicol. Ind. Health. 1999; 15(8)651–746, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Flavell D. M., Pineda T. I., Jamshidi Y., Evans D., Diamond J. R., Elkeles R. S., Bujac S. R., Miller G., Talmud P. J., Staels B., Humphries S. E. Variation in the PPARalpha gene is associated with altered function in vitro and plasma lipid concentrations in Type II diabetic subjects. Diabetologia 2000; 43(5)673–680, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Ganning A. E., Brunk U., Dallner G. Phthalate esters and their effect on the liver. Hepatology 1984; 4(3)541–547, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Ganning A. E., Brunk U., Edlund C., Elhammer A., Dallner G. Effects of prolonged administration of phthalate ester on the liver. Environ. Health Perspect. 1987; 73: 251–258, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Gariot P., Barrat E., Drouin P., Genton P., Pointel J. P., Foliguet B., Kolopp M., Debry G. Morphometric study of human hepatic cell modifications induced by fenofibrate. Metabolism 1987; 36(3)203–210, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Gerbracht U., Bursch W., Kraus P., Putz B., Reinacher M., Timmermann-Trosiener I., Schulte-Hermann R. Effects of hypolipidemic drugs nafenopin and clofibrate on phenotypic expression and cell death (apoptosis) in altered foci of rat liver. Carcinogenesis 1990; 11(4)617–624, [INFOTRIEVE], [CSA]
   Google Scholar
• Gervois P., Torra I. P., Chinetti G., Grotzinger T., Dubois G., Fruchart J. C., Fruchart-Najib J., Leitersdorf E., Staels B. A truncated human peroxisome proliferator-activated receptor alpha splice variant with dominant negative activity. Mol. Endocrinol. 1999; 13(9)1535–1549, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Gill J. H., James N. H., Roberts R. A., Dive C. The non-genotoxic hepatocarcinogen nafenopin suppresses rodent hepatocyte apoptosis induced by TGFbeta1, DNA damage and Fas. Carcinogenesis 1998; 19(2)299–304, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Goll V., Alexandre E., Viollon-Abadie C., Nicod L., Jaeck D., Richert L. Comparison of the effects of various peroxisome proliferators on peroxisomal enzyme activities, DNA synthesis, and apoptosis in rat and human hepatocyte cultures. Toxicol. Appl. Pharmacol. 1999; 160(1)21–32, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Graham M. J., Wilson S. A., Winham M. A., Spencer A. J., Rees J. A., Old S. L., Bonner F. W. Lack of peroxisome proliferation in marmoset liver following treatment with ciprofibrate for 3 years. Fund. Appl. Toxicol. 1994; 22: 58–64, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Grasl-Kraupp B., Huber W., Just W., Gibson G., Schulte-Hermann R. Enhancement of peroxisomal enzymes, cytochrome P-450 and DNA synthesis in putative preneoplastic foci of rat liver treated with the peroxisome proliferator nafenopin. Carcinogenesis 1993; 14(5)1007–1012, [INFOTRIEVE], [CSA]
   Google Scholar
• Grasl-Kraupp B., Ruttkay-Nedecky B., Mullauer L., Taper H., Huber W., Bursch W., Schulte-Hermann R. Inherent increase of apoptosis in liver tumors: implications for carcinogenesis and tumor regression. Hepatology 1997; 25(4)906–912, [INFOTRIEVE], [CSA]
   Google Scholar
• Gulick T., Cresci S., Caira T., Moore D. D., Kelly D. P. The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression. Proc. Natl. Acad. Sci. U S A. 1994; 91(23)11012–11016, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Handler J. A., Seed C. B., Bradford B. U., Thurman R. G. Induction of peroxisomes by treatment with perfluorooctanoate does not increase rates of H2O2 production in intact liver. Toxicol. Lett. 1992; 60(1)61–68, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Hanefeld M., Kemmer C., Kadner E. Relationship between morphological changes and lipid-lowering action of p-chlorphenoxyisobutyric acid (CPIB) on hepatic mitochondria and peroxisomes in man. Atherosclerosis 1983; 46(2)239–246, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Hasmall S., James N., Hedley K., Olsen K., Roberts R. Mouse hepatocyte response to peroxisome proliferators: dependency on hepatic nonparenchymal cells and peroxisome proliferator activated receptor alpha (PPARalpha). Arch. Toxicol. 2001; 75(6)357–361, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Hasmall S. C., James N. H., Macdonald N., Gonzalez F. J., Peters J. M., Roberts R. A. Suppression of mouse hepatocyte apoptosis by peroxisome proliferators: role of PPARalpha and TNFalpha. Mutat. Res. 2000a; 448(2)193–200, [INFOTRIEVE], [CSA]
   Google Scholar
• Hasmall S. C., James N. H., Macdonald N., Soames A. R., Roberts R. A. Species differences in response to diethylhexylphthalate: suppression of apoptosis, induction of DNA synthesis and peroxisome proliferator activated receptor alpha-mediated gene expression. Arch. Toxicol. 2000b; 74(2)85–91, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Hasmall S. C., James N. H., Macdonald N., West D., Chevalier S., Cosulich S. C., Roberts R. A. Suppression of apoptosis and induction of DNA synthesis in vitro by the phthalate plasticizers monoethylhexylphthalate (MEHP) and diisononylphthalate (DINP): a comparison of rat and human hepatocytes in vitro. Arch. Toxicol. 1999; 73(8–9)451–456, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Hasmall S. C., West D. A., Olsen K., Roberts R. A. Role of hepatic non-parenchymal cells in the response of rat hepatocytes to the peroxisome proliferator nafenopin in vitro. Carcinogenesis 2000c; 21(12)2159–2165, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Hays T., Rusyn I., Burns A. M., Kennett M. J., Ward J. M., Gonzalez F. J., Peters J. M. Role of peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafibrate-induced hepatocarcinogenesis and cholestasis. Carcinogenesis 2005; 26(1)219–227, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Hegi M. E., Ulrich D., Sagelsdorff P., Richter C., Lutz W. K. No measurable increase in thymidine glycol or 8-hydroxydeoxyguanosine in liver DNA of rats treated with nafenopin or choline-devoid low- methionine diet. Mutat. Res. 1990; 238(3)325–329, [INFOTRIEVE], [CSA]
   Google Scholar
• Hertz R., Bar-Tana J. Peroxisome proliferator-activated receptor (PPAR) α activation and its consequences in humans. Toxicol. Lett. 1998; 102–103: 85–90, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Hinton R. H., Mitchell F. E., Mann A., Chescoe D., Price S. C., Nunn A., Grasso P., Bridges J. W. Effects of phthalic acid esters on the liver and thyroid. Environ Health Perspect. 1986; 70: 195–210, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Hoivik D. J., Qualls C. W., Jr., Cariello N. F., Kimbrough C. L., Colton H. M., Anderson S. P., Santostefano M. J., Morgan R. J., Dahl R. R., Brown A. R., Zhao Z., Mudd P. N., Jr., Oliver W. B., Jr., Brown H. R., Miller R. T. Fibrates induce hepatic peroxisome and mitochondrial proliferation without overt evidence of cellular proliferation and oxidative stress in cynomolgus monkeys. Carcinogenesis 2004; 25(9)1757–1769, [INFOTRIEVE], [CROSSREF], [CSA]
   Web of Science ®Google Scholar
• Hurst C. H., Waxman D. J. Activation of PPARalpha and PPARgamma by environmental phthalate monoesters. Toxicol. Sci. 2003; 74(2)297–308, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Ikeda G. J., Sapienza P. P., Couvillion J. L., Farber T. M., van Loon E. J. Comparative distribution, excretion and metabolism of di-(2-ethylhexyl) phthalate in rats, dogs and miniature pigs. Food Cosmet. Toxicol. 1980; 18(6)637–642, [INFOTRIEVE], [CSA]
   Google Scholar
• Isenberg J. S., Kamendulis L. M., Ackley D. C., Smith J. H., Pugh G. W., Jr., McKee R. H., Klaunig J. E. Reversibility and persistence of di-2-ethylhexyl phthalate (DEHP)- and phenobarbital-induced hepatocellular changes in rodents. Toxicol. Sci. 2001; 64(2)192–199, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Isenberg J. S., Kamendulis L. M., Smith J. H., Ackley D. C., Pugh G., Jr., Lington A. W., Klaunig J. E. Effects of Di-2-ethylhexyl phthalate (DEHP) on gap-junctional intercellular communication (GJIC), DNA synthesis, and peroxisomal beta oxidation (PBOX) in rat, mouse, and hamster liver. Toxicol. Sci. 2000; 56(1)73–85, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Issemann I., Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 1990; 347(6294)645–650, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Ito Y., Yokota H., Wang R., Yamanoshita O., Ichihara G., Wang H., Kurata Y., Takagi K., Nakajima T. Species differences in the metabolism of di(2-ethylhexyl) phthalate (DEHP) in several organs of mice, rats, and marmosets. Arch. Toxicol. 2005; 79(3)147–154, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• James N. H., Roberts R. A. The peroxisome proliferator class of non-genotoxic hepatocarcinogens synergize with epidermal growth factor to promote clonal expansion of initiated rat hepatocytes. Carcinogenesis 1994; 15(12)2687–2694, [INFOTRIEVE], [CSA]
   Google Scholar
• James N. H., Roberts R. A. Species differences in the clonal expansion of hepatocytes in response to the coaction of epidermal growth factor and nafenopin, a rodent hepatocarcinogenic peroxisome proliferator. Fundam. Appl. Toxicol. 1995; 26(1)143–149, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• James N. H., Soames A. R., Roberts R. A. Suppression of hepatocyte apoptosis and induction of DNA synthesis by the rat and mouse hepatocarcinogen diethylhexylphlathate (DEHP) and the mouse hepatocarcinogen 1,4-dichlorobenzene (DCB). Arch. Toxicol. 1998; 72(12)784–790, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Kamendulis L. M., Isenberg J. S., Smith J. H., Pugh G., Jr., Lington A. W., Klaunig J. E. Comparative effects of phthalate monoesters on gap junctional intercellular communication and peroxisome proliferation in rodent and primate hepatocytes. J. Toxicol. Environ. Health A. 2002; 65(8)569–588, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Kasai H. Analysis of a form of oxidative DNA damage, 8-hydroxy-2'-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat. Res. 1997; 387(3)147–163, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Kasai H., Okada Y., Nishimura S., Rao M. S., Reddy J. K. Formation of 8-hydroxydeoxyguanosine in liver DNA of rats following long-term exposure to a peroxisome proliferator. Cancer Res. 1989; 49(10)2603–2605, [INFOTRIEVE], [CSA]
   Google Scholar
• Kavlock R., Boekelheide K., Chapin R., Cunningham M., Faustman E., Foster P., Golub M., Henderson R., Hinberg I., Little R., Seed J., Shea K., Tabacova S., Tyl R., Williams P., Zacharewski T. NTP Center for the Evaluation of Risks to Human Reproduction: phthalates expert panel report on the reproductive and developmental toxicity of di(2-ethylhexyl) phthalate. Reprod. Toxicol. 2002; 16(5)529–653, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Keller B. J., Yamanaka H., Thurman R. G. Inhibition of mitochondrial respiration and oxygen-dependent hepatotoxicity by six structurally dissimilar peroxisomal proliferating agents. Toxicology 1992; 71(1–2)49–61, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Klaunig J. E., Babich M. A., Baetcke K. P., Cook J. C., Corton J. C., David R. M., Deluca J. G., Lai D. Y., McKee R. H., Peters J. M., Roberts R. A., Fenner-Crisp P. A. PPARalpha agonist-induced rodent tumors: modes of action and human relevance. Crit. Rev. Toxicol. 2003; 33(6)655–780, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Klaunig J. E., Kamendulis L. M. The role of oxidative stress in carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 2004; 44: 239–267, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Klaunig J. E., Ruch R. J. Role of inhibition of intercellular communication in carcinogenesis. Lab. Invest. 1990; 62(2)135–146, [INFOTRIEVE], [CSA]
   Google Scholar
• Klaunig J. E., Ruch R. J., Deangelo A. B., Kaylor W. H. Inhibition of mouse hepatocyte intercellular communication by phthalate monoesters. Cancer Lett. 1988; 43(1–2)65–71, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Klaunig J. E., Xu Y., Isenberg J. S., Bachowski S., Kolaja K. L., Jiang J., Stevenson D. E., Walborg E. F., Jr. The role of oxidative stress in chemical carcinogenesis. Environ. Health Perspect. 1998; 106(Suppl 1)289–295, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Koch H. M., Drexler H., Angerer J. An estimation of the daily intake of di(2-ethylhexyl)phthalate (DEHP) and other phthalates in the general population. Int. J. Hyg. Environ. Health. 2003; 206(2)77–83, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Kohli V., Selzner M., Madden J. F., Bentley R. C., Clavien P. A. Endothelial cell and hepatocyte deaths occur by apoptosis after ischemia-reperfusion injury in the rat liver. Transplantation 1999; 67(8)1099–1105, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Kroetz D. L., Yook P., Costet P., Bianchi P., Pineau T. Peroxisome proliferator-activated receptor alpha controls the hepatic CYP4A induction adaptive response to starvation and diabetes. J. Biol. Chem. 1998; 273(47)31581–31589, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Kurata Y., Kidachi F., Yokoyama M., Toyota N., Tsuchitani M., Katoh M. Subchronic toxicity of Di(2-ethylhexyl)phthalate in common marmosets: lack of hepatic peroxisome proliferation, testicular atrophy, or pancreatic acinar cell hyperplasia. Toxicol. Sci. 1998; 42(1)49–56, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Lake B. G., Gangolli S. D., Grasso P., Lloyd A. G. Studies on the hepatic effects of orally administered di-(2-ethylhexyl) phthalate in the rat. Toxicol. Appl. Pharmacol. 1975; 32(2)355–367, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Lake B. G., Kozlen S. L., Evans J. G., Gray T. J., Young P. J., Gangolli S. D. Effect of prolonged administration of clofibric acid and di-(2- ethylhexyl)phthalate on hepatic enzyme activities and lipid peroxidation in the rat. Toxicology 1987; 44(2)213–228, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Lapinskas P. J., Brown S., Leesnitzer L. M., Blanchard S., Swanson C., Cattley R. C., Corton J. C. Role of PPARalpha in mediating the effects of phthalates and metabolites in the liver. Toxicology 2005; 207(1)149–163, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Lawrence J. W., Wollenberg G. K., Deluca J. G. Tumor necrosis factor alpha is not required for WY14,643-induced cell proliferation. Carcinogenesis 2001; 22(3)381–386, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Lee S. S., Pineau T., Drago J., Lee E. J., Owens J. W., Kroetz D. L., Fernandez-Salguero P. M., Westphal H., Gonzalez F. J. Targeted disruption of the alpha isoform of the peroxisome proliferator- activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell. Biol. 1995; 15(6)3012–3022, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Maloney E. K., Waxman D. J. Trans-activation of PPARalpha and PPARgamma by structurally diverse environmental chemicals. Toxicol. Appl. Pharmacol. 1999; 161(2)209–218, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Mandard S., Muller M., Kersten S. Peroxisome proliferator-activated receptor alpha target genes. Cell. Mol. Life Sci. 2004; 61(4)393–416, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Marsman D. S., Cattley R. C., Conway J. G., Popp J. A. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2- pyrimidinylthio]acetic acid (Wy-14,643) in rats. Cancer Res. 1988; 48(23)6739–6744, [INFOTRIEVE], [CSA]
   Google Scholar
• Melnick R. L., Schiller C. M. Effect of phthalate esters on energy coupling and succinate oxidation in rat liver mitochondria. Toxicology 1985; 34(1)13–27, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Mitchell F. E., Price S. C., Hinton R. H., Grasso P., Bridges J. W. Time and dose-response study of the effects on rats of the plasticizer di(2-ethylhexyl) phthalate. Toxicol. Appl. Pharmacol. 1985; 81(3 Pt 1)371–392, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Morimura K., Cheung C., Ward J. M., Reddy J. K., Gonzalez F. J. Differential susceptibility of mice humanized for peroxisome proliferator-activated receptor (alpha) to Wy-14,643-induced liver tumorigenesis. Carcinogenesis. 2006, (in Press)[CSA]
   Google Scholar
• Mukherjee R., Jow L., Noonan D., McDonnell D. P. Human and rat peroxisome proliferator activated receptors (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators. J. Steroid. Biochem. Mol. Biol. 1994; 51(3–4)157–166, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Nair N., Kurup C. K. Effect of administration of diethylhexyl phthalate on the function and turnover of rat hepatic mitochondria. Biochim. Biophys. Acta. 1987; 925(3)332–340, [INFOTRIEVE], [CSA]
   Google Scholar
• National Toxicology Program. Carcinogenesis Bioassay of Di(2-ethylhexyl)phthalate (CAS No. 117-81-7) in F344 Rats and B6C3F1 Mice (Feed Studies). Natl. Toxicol. Program. Tech. Rep. Ser. 1982; 217: 1–127, [CSA]
   PubMedGoogle Scholar
• Nemali M. R., Usuda N., Reddy M. K., Oyasu K., Hashimoto T., Osumi T., Rao M. S., Reddy J. K. Comparison of constitutive and inducible levels of expression of peroxisomal beta-oxidation and catalase genes in liver and extrahepatic tissues of rat. Cancer Res. 1988; 48(18)5316–5324, [INFOTRIEVE], [CSA]
   Google Scholar
• Oesterle D., Deml E. Promoting activity of di(2-ethylhexyl)phthalate in rat liver foci bioassay. J. Cancer Res. Clin. Oncol. 1988; 114(2)133–136, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Palmer C. N., Hsu M. H., Griffin K. J., Raucy J. L., Johnson E. F. Peroxisome proliferator activated receptor-alpha expression in human liver. Mol. Pharmacol. 1998; 53(1)14–22, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Parzefall W., Berger W., Kainzbauer E., Teufelhofer O., Schulte-Hermann R., Thurman R. G. Peroxisome proliferators do not increase DNA synthesis in purified rat hepatocytes. Carcinogenesis 2001; 22(3)519–523, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Peraza M. A., Burdick A. D., Marin H. E., Gonzalez F. J., Peters J. M. The Toxicology of Ligands for Peroxisome Proliferator-Activated Receptors (PPAR). Toxicol. Sci. 2006; 90(2)269–295, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Peters J. M., Cattley R. C., Gonzalez F. J. Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643. Carcinogenesis 1997; 18(11)2029–2033, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Peters J. M., Cheung C., Gonzalez F. J. Peroxisome proliferator-activated receptor-alpha and liver cancer: where do we stand?. J. Mol. Med. 2005; 83(10)774–785, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Peters J. M., Rusyn I., Rose M. L., Gonzalez F. J., Thurman R. G. Peroxisome proliferator-activated receptor alpha is restricted to hepatic parenchymal cells, not Kupffer cells: implications for the mechanism of action of peroxisome proliferators in hepatocarcinogenesis. Carcinogenesis 2000; 21(4)823–826, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Posnick L. M., Samson L. D. Imbalanced base excision repair increases spontaneous mutation and alkylation sensitivity in Escherichia coli. J. Bacteriol. 1999; 181(21)6763–6771, [INFOTRIEVE], [CSA]
   Google Scholar
• Pugh G., Jr., Isenberg J. S., Kamendulis L. M., Ackley D. C., Clare L. J., Brown R., Lington A. W., Smith J. H., Klaunig J. E. Effects of di-isononyl phthalate, di-2-ethylhexyl phthalate, and clofibrate in cynomolgus monkeys. Toxicol. Sci. 2000; 56(1)181–188, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Qu B., Li Q., Wong K. P., Tan T. M., Halliwell B. Mechanism of clofibrate hepatotoxicity: Mitochondrial damage and oxidative stress in hepatocytes. Free Radic. Biol. Med. 2001; 31(5)659–669, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Randerath E., Randerath K., Reddy R., Danna T. F., Rao M. S., Reddy J. K. Induction of rat liver DNA alterations by chronic administration of peroxisome proliferators as detected by 32P-postlabeling. Mutat. Res. 1991; 247: 65–76, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Reddy J. K., Azarnoff D. L., Hignite C. E. Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens. Nature 1980; 283(5745)397–398, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Reddy J. K., Chu R. Peroxisome proliferator-induced pleiotropic responses: pursuit of a phenomenon. Ann. N. Y. Acad. Sci. 1996; 804: 176–201, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Reddy J. K., Goel S. K., Nemali M. R., Carrino J. J., Laffler T. G., Reddy M. K., Sperbeck S. J., Osumi T., Hashimoto T., Lalwani N. D. Transcription regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators. Proc. Natl. Acad. Sci. U S A. 1986; 83(6)1747–1751, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Reddy J. K., Moody D. E., Azarnoff D. L., Rao M. S. Di-(2-ethylhexyl)phthalate: an industrial plasticizer induces hypolipidemia and enhances hepatic catalase and carnitine acetyltransferase activities in rat and mice. Life Sci. 1976a; 18(9)941–945, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Reddy J. K., Rao M. S. Oxidative DNA damage caused by persistent peroxisome proliferation: its role in hepatocarcinogenesis. Mutat. Res. 1989; 214(1)63–68, [INFOTRIEVE], [CSA]
   Google Scholar
• Reddy J. K., Rao M. S., Azarnoff D. L., Sell S. Mitogenic and carcinogenic effects of a hypolipidemic peroxisome proliferator, [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14, 643), in rat and mouse liver. Cancer Res. 1979; 39(1)152–161, [INFOTRIEVE], [CSA]
   Google Scholar
• Reddy J. K., Rao S., Moody D. E. Hepatocellular carcinomas in acatalasemic mice treated with nafenopin, a hypolipidemic peroxisome proliferator. Cancer Res. 1976b; 36(4)1211–1217, [INFOTRIEVE], [CSA]
   Google Scholar
• Rhodes C., Orton T. C., Pratt I. S., Batten P. L., Bratt H., Jackson S. J., Elcombe C. R. Comparative pharmacokinetics and subacute toxicity of di(2-ethylhexyl) phthalate (DEHP) in rats and marmosets: extrapolation of effects in rodents to man. Environ. Health Perspect. 1986; 65: 299–307, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Roberts R. A. Peroxisome proliferators: Mechanisms of adverse effects in rodents and molecular basis for species differences. Arch. Toxicol. 1999; 73(8–9)413–418, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Roberts R. A., James N. H., Cosulich S., Hasmall S. C., Orphanides G. Role of cytokines in non-genotoxic hepatocarcinogenesis: cause or effect? Toxicol. Lett. 2001; 120(1–3)301–306, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Roberts R. A., James N. H., Hasmall S. C., Holden P. R., Lambe K., Macdonald N., West D., Woodyatt N. J., Whitcome D. Apoptosis and proliferation in nongenotoxic carcinogenesis: species differences and role of PPARalpha. Toxicol. Lett. 2000; 112–113: 49–57, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Roberts R. A., James N. H., Woodyatt N. J., Macdonald N., Tugwood J. D. Evidence for the suppression of apoptosis by the peroxisome proliferator activated receptor alpha. Carcinogenesis 1998; 19(1)43–48, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Roberts R. A., Soames A. R., Gill J. H., James N. H., Wheeldon E. B. Non-genotoxic hepatocarcinogens stimulate DNA synthesis and their withdrawal induces apoptosis, but in different hepatocyte populations. Carcinogenesis 1995; 16(8)1693–1698, [INFOTRIEVE], [CSA]
   Google Scholar
• Roglans N., Bellido A., Rodriguez C., Cabrero A., Novell F., Ros E., Zambon D., Laguna J. C. Fibrate treatment does not modify the expression of acyl coenzyme A oxidase in human liver. Clin. Pharmacol. Ther. 2002; 72(6)692–701, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Rolfe M., James N. H., Roberts R. A. Tumour necrosis factor alpha (TNF alpha) suppresses apoptosis and induces DNA synthesis in rodent hepatocytes: a mediator of the hepatocarcinogenicity of peroxisome proliferators? Carcinogenesis 1997; 18(11)2277–2280, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Rose M. L., Germolec D., Arteel G. E., Schoonhoven R., Thurman R. G. Dietary glycine prevents increases in hepatocyte proliferation caused by the peroxisome proliferator WY-14,643. Chem. Res. Toxicol. 1997a; 10(10)1198–1204, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Rose M. L., Germolec D. R., Schoonhoven R., Thurman R. G. Kupffer cells are causally responsible for the mitogenic effect of peroxisome proliferators. Carcinogenesis 1997b; 18(8)1453–1456, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Rose M. L., Rivera C. A., Bradford B. U., Graves L. M., Cattley R. C., Schoonhoven R., Swenberg J. A., Thurman R. G. Kupffer cell oxidant production is central to the mechanism of peroxisome proliferators. Carcinogenesis 1999a; 20(1)27–33, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Rose M. L., Rusyn I., Bojes H. K., Belyea J., Cattley R. C., Thurman R. G. Role of Kupffer cells and oxidants in signaling peroxisome proliferator- induced hepatocyte proliferation. Mutat. Res. 2000; 448(2)179–192, [INFOTRIEVE], [CSA]
   Google Scholar
• Rose M. L., Rusyn I., Bojes H. K., Germolec D. R., Luster M., Thurman R. G. Role of Kupffer cells in peroxisome proliferator-induced hepatocyte proliferation. Drug. Metab. Rev. 1999b; 31(1)87–116, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Rusyn I., Asakura S., Pachkowski B., Bradford B. U., Denissenko M. F., Peters J. M., Holland S. M., Reddy J. K., Cunningham M. L., Swenberg J. A. Expression of base excision DNA repair genes is a sensitive biomarker for in vivo detection of chemical-induced chronic oxidative stress: Identification of the molecular source of radicals responsible for DNA damage by peroxisome proliferators. Cancer Res. 2004; 64(3)1050–1057, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Rusyn I., Denissenko M. F., Wong V. A., Butterworth B. E., Cunningham M. L., Upton P. B., Thurman R. G., Swenberg J. A. Expression of base excision repair enzymes in rat and mouse liver is induced by peroxisome proliferators and is dependent upon carcinogenic potency. Carcinogenesis 2000a; 21(12)2141–2145, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Rusyn I., Kadiiska M. B., Dikalova A., Kono H., Yin M., Tsuchiya K., Mason R. P., Peters J. M., Gonzalez F. J., Segal B. H., Holland S. M., Thurman R. G. Phthalates rapidly increase production of reactive oxygen species in vivo: role of Kupffer cells. Mol. Pharmacol. 2001; 59(4)744–750, [INFOTRIEVE], [CSA]
   Google Scholar
• Rusyn I., Rose M. L., Bojes H. K., Thurman R. G. Novel role of oxidants in the molecular mechanism of action of peroxisome proliferators. Antiox. Redox. Signal. 2000b; 2: 607–621, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Rusyn I., Tsukamoto H., Thurman R. G. WY-14,643 rapidly activates nuclear factor kappaB in Kupffer cells before hepatocytes. Carcinogenesis 1998; 19(7)1217–1222, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Rusyn I., Yamashina S., Segal B. H., Schoonhoven R., Holland S. M., Cattley R. C., Swenberg J. A., Thurman R. G. Oxidants from nicotinamide adenine dinucleotide phosphate oxidase are involved in triggering cell proliferation in the liver due to peroxisome proliferators. Cancer Res. 2000c; 60(17)4798–4803, [INFOTRIEVE], [CSA]
   Google Scholar
• Sapone A., Peters J. M., Sakai S., Tomita S., Papiha S. S., Dai R., Friedman F. K., Gonzalez F. J. The human peroxisome proliferator-activated receptor alpha gene: identification and functional characterization of two natural allelic variants. Pharmacogenetics 2000; 10(4)321–333, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Sausen P. J., Lee D. C., Rose M. L., Cattley R. C. Elevated 8-hydroxydeoxyguanosine in hepatic DNA of rats following exposure to peroxisome proliferators: relationship to mitochondrial alterations. Carcinogenesis 1995; 16(8)1795–1801, [INFOTRIEVE], [CSA]
   Google Scholar
• Schmid P., Schlatter C. Excretion and metabolism of di(2-ethylhexyl)phthalate in man. Xenobiotica 1985; 15(3)251–256, [INFOTRIEVE], [CSA]
   Web of Science ®Google Scholar
• Schrader M., Fahimi H. D. Mammalian peroxisomes and reactive oxygen species. Histochem. Cell. Biol. 2004; 122(4)383–393, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Seree E., Villard P. H., Pascussi J. M., Pineau T., Maurel P., Nguyen Q. B., Fallone F., Martin P. M., Champion S., Lacarelle B., Savouret J. F., Barra Y. Evidence for a new human CYP1A1 regulation pathway involving PPAR-alpha and 2 PPRE sites. Gastroenterology 2004; 127(5)1436–1445, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Shaban Z., El Shazly S., Ishizuka M., Kimura K., Kazusaka A., Fujita S. PPARalpha-dependent modulation of hepatic CYP1A by clofibric acid in rats. Arch. Toxicol. 2004; 78(9)496–507, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Sher T., Yi H. F., McBride O. W., Gonzalez F. J. cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor. Biochemistry 1993; 32(21)5598–5604, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Shipley J. M., Waxman D. J. Simultaneous, bidirectional inhibitory crosstalk between PPAR and STAT5b. Toxicol. Appl. Pharmacol. 2004; 199(3)275–284, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Short R. D., Robinson E. C., Lington A. W., Chin A. E. Metabolic and peroxisome proliferation studies with di(2-ethylhexyl)phthalate in rats and monkeys. Toxicol. Ind. Health. 1987; 3(2)185–195, [INFOTRIEVE], [CSA]
   Google Scholar
• Silva M. J., Barr D. B., Reidy J. A., Kato K., Malek N. A., Hodge C. C., Hurtz D., III, Needham L. L., Brock J. W. Glucuronidation patterns of common urinary and serum monoester phthalate metabolites. Arch. Toxicol. 2003; 77(10)561–567, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Smith J. H., Isenberg J. S., Pugh G. M., Jr., Ackley D., Lington A. W., Klaunig J. E. Comparative in vivo hepatic effects of Di-isononyl phthalate (DINP) and related C7-C11 dialkyl phthalates on gap junctional intercellular communication (GJIC), peroxisomal beta-oxidation (PBOX), and DNA synthesis in rat and mouse liver. Toxicol. Sci. 2000; 54(2)312–321, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Smith-Oliver T., Butterworth B. E. Correlation of the carcinogenic potential of di(2-ethylhexyl)phthalate (DEHP) with induced hyperplasia rather than with genotoxic activity. Mutat. Res. 1987; 188(1)21–28, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Soliman M. S., Cunningham M. L., Morrow J. D., Roberts L. J., Badr M. Z. Evidence against peroxisome proliferation-induced hepatic oxidative damage. Biochem. Pharmacol. 1997; 53(9)1369–1374, [INFOTRIEVE], [CSA]
   Google Scholar
• Sumanasekera W. K., Tien E. S., Davis J. W., Turpey R., Perdew G. H., Vanden Heuvel J. P. Heat shock protein-90 (Hsp90) acts as a repressor of peroxisome proliferator-activated receptor-alpha (PPARalpha) and PPARbeta activity. Biochemistry 2003a; 42(36)10726–10735, [INFOTRIEVE], [CSA]
   Google Scholar
• Sumanasekera W. K., Tien E. S., Turpey R., Vanden Heuvel J. P., Perdew G. H. Evidence that peroxisome proliferator-activated receptor alpha is complexed with the 90-kDa heat shock protein and the hepatitis virus B X-associated protein 2. J. Biol. Chem. 2003b; 278(7)4467–4473, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Takagi A., Sai K., Umemura T., Hasegawa R., Kurokawa Y. Significant increase of 8-hydroxydeoxyguanosine in liver DNA of rats following short-term exposure to the peroxisome proliferators di(2- ethylhexyl)phthalate and di(2-ethylhexyl)adipate. Jpn. J. Cancer. Res. 1990; 81(3)213–215, [INFOTRIEVE], [CSA]
   Google Scholar
• Tanaka A., Adachi T., Takahashi T., Yamaha T. Biochemical studies on phthalic esters I. Elimination, distribution and metabolism of di-(2-ethylhexyl)phthalate in rats. Toxicology 1975; 4(2)253–264, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Tomaszewski K. E., Agarwal D. K., Melnick R. L. In vitro steady-state levels of hydrogen peroxide after exposure of male F344 rats and female B6C3F1 mice to hepatic peroxisome proliferators. Carcinogenesis 1986; 7(11)1871–1876, [INFOTRIEVE], [CSA]
   Google Scholar
• Comparative toxicology of hypolipidaemic fibrates. Taylor & Francis, London 1995
   Google Scholar
• Vohl M. C., Lepage P., Gaudet D., Brewer C. G., Betard C., Perron P., Houde G., Cellier C., Faith J. M., Despres J. P., Morgan K., Hudson T. J. Molecular scanning of the human PPARa gene: association of the L162v mutation with hyperapobetalipoproteinemia. J. Lipid. Res. 2000; 41(6)945–952, [INFOTRIEVE], [CSA]
   Google Scholar
• Voskoboinik I., Ooi S. G., Drew R., Ahokas J. T. Peroxisome proliferators increase the formation of BPDE-DNA adducts in isolated rat hepatocytes. Toxicology 1997; 122(1–2)81–91, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Vu-Dac N., Chopin-Delannoy S., Gervois P., Bonnelye E., Martin G., Fruchart J. C., Laudet V., Staels B. The nuclear receptors peroxisome proliferator-activated receptor alpha and Rev-erbalpha mediate the species-specific regulation of apolipoprotein A-I expression by fibrates. J. Biol. Chem. 1998; 273(40)25713–25720, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Vu-Dac N., Gervois P., Jakel H., Nowak M., Bauge E., Dehondt H., Staels B., Pennacchio L. A., Rubin E. M., Fruchart-Najib J., Fruchart J. C. Apolipoprotein A5, a crucial determinant of plasma triglyceride levels, is highly responsive to peroxisome proliferator-activated receptor alpha activators. J. Biol. Chem. 2003; 278(20)17982–17985, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Walgren J. E., Kurtz D. T., McMillan J. M. Expression of PPAR(alpha) in human hepatocytes and activation by trichloroacetate and dichloroacetate. Res. Commun. Mol. Pathol. Pharmacol. 2000; 108(1–2)116–132, [INFOTRIEVE], [CSA]
   Google Scholar
• Ward J. M., Diwan B. A., Ohshima M., Hu H., Schuller H. M., Rice J. M. Tumor-initiating and promoting activities of di(2-ethylhexyl) phthalate in vivo and in vitro. Environ. Health Perspect. 1986; 65: 279–291, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Ward J. M., Hagiwara A., Anderson L. M., Lindsey K., Diwan B. A. The chronic hepatic or renal toxicity of di(2-ethylhexyl) phthalate, acetaminophen, sodium barbital, and phenobarbital in male B6C3F1 mice: autoradiographic, immunohistochemical, and biochemical evidence for levels of DNA synthesis not associated with carcinogenesis or tumor promotion. Toxicol. Appl. Pharmacol. 1988; 96(3)494–506, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Ward J. M., Peters J. M., Perella C. M., Gonzalez F. J. Receptor and nonreceptor-mediated organ-specific toxicity of di(2-ethylhexyl)phthalate (DEHP) in peroxisome proliferator-activated receptor alpha-null mice. Toxicol. Pathol. 1998; 26(2)240–246, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Ward J. M., Rice J. M., Creasia D., Lynch P., Riggs C. Dissimilar patterns of promotion by di(2-ethylhexyl)phthalate and phenobarbital of hepatocellular neoplasia initiated by diethylnitrosamine in B6C3F1 mice. Carcinogenesis 1983; 4(8)1021–1029, [INFOTRIEVE], [CSA]
   Google Scholar
• Weglarz T. C., Sandgren E. P. Cell cross-talk mediates PPARalpha null hepatocyte proliferation after peroxisome proliferator exposure. Carcinogenesis 2004; 25(1)107–112, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Wheeler M. D., Smutney O. M., Check J. F., Rusyn I., Schulte-Hermann R., Thurman R. G. Impaired Ras membrane association and activation in PPARalpha knockout mice after partial hepatectomy. Am. J. Physiol. Gastrointest. Liver Physiol. 2003; 284(2)G302–G312, [INFOTRIEVE], [CSA]
   Google Scholar
• Winberg L. D., Badr M. Z. Mechanism of phthalate-induced inhibition of hepatic mitochondrial beta-oxidation. Toxicol. Lett. 1995; 76(1)63–69, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Woodyatt N. J., Lambe K. G., Myers K. A., Tugwood J. D., Roberts R. A. The peroxisome proliferator (PP) response element upstream of the human acyl CoA oxidase gene is inactive among a sample human population: significance for species differences in response to PPs. Carcinogenesis 1999; 20(3)369–372, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Yeldandi A. V., Rao M. S., Reddy J. K. Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis. Mutat. Res. 2000; 448(2)159–177, [INFOTRIEVE], [CSA]
   Google Scholar
• Youssef J. A., Bouziane M., Badr M. Z. Age-dependent effects of nongenotoxic hepatocarcinogens on liver apoptosis in vivo. Mech. Aging Dev. 2003; 124(3)333–340, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Yu S., Cao W. Q., Kashireddy P., Meyer K., Jia Y., Hughes D. E., Tan Y., Feng J., Yeldandi A. V., Rao M. S., Costa R. H., Gonzalez F. J., Reddy J. K. Human peroxisome proliferator-activated receptor alpha (PPARalpha) supports the induction of peroxisome proliferation in PPARalpha-deficient mouse liver. J. Biol. Chem. 2001; 276(45)42485–42491, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Zhou S., Wallace K. B. The effect of peroxisome proliferators on mitochondrial bioenergetics. Toxicol. Sci. 1999; 48(1)82–89, [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar